tiprankstipranks
Trending News
More News >
Edesa Biotech Inc (EDSA)
NASDAQ:EDSA
US Market

Edesa Biotech (EDSA) Income Statement

Compare
291 Followers

Edesa Biotech Income Statement

Last quarter (Q4 2025), Edesa Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Edesa Biotech's net income was $-2.23M. See Edesa Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -119.27K$ -186.05K$ -183.47K$ -118.19K$ -118.79K
Operating Expenses
$ 7.79M$ 7.01M$ 9.22M$ 17.59M$ 13.34M
Depreciation and Amortization
$ 119.27K$ 186.05K$ 183.47K$ 118.19K$ 118.79K
EBITDA
$ -7.07M$ -5.98M$ -8.19M$ -17.43M$ -13.22M
Operating Income
$ -7.91M$ -7.01M$ -9.22M$ -18.37M$ -23.68M
Other Income/Expenses
$ 726.84K$ 845.50K$ 849.14K$ 822.67K$ 10.34M
Pretax Income
$ -7.18M$ -6.17M$ -8.37M$ -17.55M$ -13.34M
Net Income
$ -7.19M$ -6.17M-$ -17.55M$ -13.34M
Per Share Metrics
Basic EPS
$ -1.27$ -1.93$ -2.93$ -8.37$ -7.74
Diluted EPS
$ -1.27$ -1.93$ -2.93$ -8.37$ -7.73
Weighted Average Shares Outstanding
5.68M 3.20M 2.86M 2.10M 1.73M
Weighted Average Shares Outstanding (Diluted)
5.68M 3.20M 2.86M 2.10M 1.73M
Currency in USD

Edesa Biotech Earnings and Revenue History